| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |